Welcome to Sullivan Nicolaides Pathology
In order for us to direct you to the most relevant section of our website, please make a selection below.
| Coronavirus testing
As the SARS-CoV-2 outbreak (previously known as 2019-nCoV) progresses and the capacity to test has increased, the restrictions on who should be tested have changed over time.
Testing is recommended for those patients who fulfil the case definition for investigation for COVID-19 infection.
Test for SARS-CoV-2 in patients who have:
Also consider SARS-CoV-2 testing for patients who have travelled to Thailand, Hong Kong, Japan, Singapore, or Indonesia in the 14 days before the onset of symptoms.
Clinical judgement should be used to determine the need for testing in patients who do not meet the epidemiological or clinical criteria above.
Public health approval is no longer required to request testing.
The preferred specimens include combined nasopharyngeal and oropharyngeal flocked swab.
If a sputum sample is available, this should also be submitted.
All samples will undergo normal respiratory virus testing in addition to coronavirus.
In high-risk patients, a serum sample may also be collected for future antibody testing.
As of 30 January 2020, “COVID-19”, the infection caused by SARS-CoV-2, is a notifiable condition in Queensland.
SNP offers collection of these samples at a large number of dedicated collection centres, by trained staff, who can safely collect these samples.
Last information content update 1:35pm 18 February 2020